contraindications to glp 1 agonist Glucagon-like peptide-1 receptor agonists(GLP-1RAs)** GLP-1 agonists are a class of drugs that people use manage type 2 diabetes. # # GLP-1 is an incretin, which is one of the gut GLP-1 Receptor Agonists and vision

3.3.2 Harms: Risk of Ketoacidosis: The major concern is the development of diabetic ketoacidosis (DKA), including euglycemic DKA

Importantly, significant imbalances in concomitant therapies were observed: SGLT2 inhibitors and DPP4 inhibitors were more prevalent in the control group (100% and 64%, respectively) compared with the GLP-1 RA group (48% and 0%

A Narrative Review of Cardiovascular Outcome Trials

2021M703724)

Tirzepatide dose-dependently leads to clinically significant reductions in glycemic parameters and body weight and has been shown to have stronger effects in reducing these parameters than standard antidiabetic therapy